Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
This is a completed update on the PROPOSE Quality study evaluating Preotact in postmenopausal osteoporosis, with a focus on quality of life.
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture [Phase 3]
This document provides an update on a Phase 3 trial evaluating zoledronic acid to reduce subsequent osteoporotic fractures after a hip fract…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men [Phase 3]
A Phase 3 trial evaluates the efficacy and safety of zoledronic acid for osteoporosis in men. The update provides results from that study.
-
FDA approval · 2012-04-27FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for PROLIA (denosumab) filed by Amgen.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid [Phase 3]
A Phase 3 study evaluating switching osteoporosis patients from oral bisphosphonates to zoledronic acid has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate [Phase 3]
This document reports the completion of a Phase 3 clinical trial comparing zoledronic acid to an oral bisphosphonate for osteoporosis.
-
FDA approval · 2012-04-25FDA Approved: CALCITONIN SALMON — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for Calcitonin Salmon from Apotex Corp., updating the approved product's regulatory status.
-
CLINICAL_TRIALS research · 2012-04-06Clinical Trial Update: Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors [NA]
This completed clinical trial assesses whether assessing osteoporosis risk influences physician and patient behaviors. The study focuses on …
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Foot Orthoses and Elderly Women With Osteoporosis [NA]
A clinical trial evaluating foot orthoses for elderly women with osteoporosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors [Phase 3]
This Phase 3 trial evaluated approaches to diminished bone mineral density in survivors of acute lymphoblastic leukemia, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy [Phase 3]
Phase 3 clinical trial evaluating oral bisphosphonates for osteoporosis in non-walking children with cerebral palsy was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: The Effect of Chymosin on the Intestinal Absorption of Calcium [Phase 1]
A Phase 1 study evaluating whether chymosin affects intestinal calcium absorption in individuals with osteoporosis or osteopenia.
-
FDA approval · 2012-03-19FDA Approved: IBANDRONATE SODIUM — Original Application (Apotex Corp)
FDA approved the original application for ibandronate sodium by Apotex Corp, enabling a generic version of the osteoporosis treatment.
-
FDA approval · 2012-03-19FDA Approved: IBANDRONATE SODIUM — Original Application (Bionpharma Inc.)
FDA approved the original generic application for ibandronate sodium by Bionpharma Inc., enabling a generic version of the osteoporosis trea…
-
EMA label_change · 2012-03-16European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings
The EMA confirms a positive overall benefit-risk for Protelos/Osseor but recommends new contraindications and revised warnings.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Effect of High-Calcium Milk and Weight-Bearing Exercise on Bone Mineral Status of Pre-Pubertal Girls [NA]
A completed clinical trial assessing whether high-calcium milk and weight-bearing exercise improve bone mineral status in pre-pubertal girls…
-
FDA approval · 2012-03-13FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
FDA approval · 2012-03-12FDA Approved: BINOSTO — Original Application (Radius Health, Inc.)
FDA approved Radius Health's BINOSTO (alendronate sodium) under an Original Application, granting regulatory approval for this product.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Melatonin Osteoporosis Prevention Study [Phase 1]
A Phase 1 trial evaluating melatonin for osteoporosis and osteopenia prevention has completed, with results posted in 2012.
-
CLINICAL_TRIALS research · 2012-03-08Clinical Trial Update: Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD) [NA]
This document provides an update on a clinical trial exploring osteoporosis in patients with chronic obstructive pulmonary disease, but the …
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women [Phase 4]
Phase 4 clinical trial update comparing teriparatide and zoledronic acid for bone outcomes in postmenopausal women with osteoporosis, with r…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Effects Of Unilateral Vibration On Contralateral Forearm Muscle Activity [NA]
A completed clinical trial update examining how unilateral vibration affects contralateral forearm muscle activity.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Risedronate in Postmenopausal Women With Low Bone Density [Phase 2]
Phase 2 trial of risedronate in postmenopausal women with low bone density has completed.
-
FDA approval · 2012-02-06FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax (alendronate sodium) from Organon LLC, updating the drug's labeling and/or approved …
-
CLINICAL_TRIALS withdrawal · 2012-02-03Clinical Trial Update: An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness
An open clinical trial investigating the influence of aminobiphosphonates on arterial stiffness has been withdrawn.